カテゴリー： QYResearch, 世界, 医療/バイオ

世界の感染症POC診断市場インサイト及び予測（イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他）

◆英語タイトル：Global Infectious Disease POC Diagnostic Market Insights, Forecast to 2028

QYResearchが発行した調査報告書（QY22JLX09588）◆商品コード：QY22JLX09588
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2022年7月（※2025年版があります。お問い合わせください。）
◆ページ数：114
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

COVID-19のパンデミックにより、感染症POC診断のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に感染症POC診断の世界市場のxxx％を占める「イムノクロマトグラフィー」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院ベッドサイド」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
感染症POC診断の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの感染症POC診断市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

感染症POC診断のグローバル主要企業には、F. Hoffmann-La Roche、Thermo Fisher Scientific、Abbott Laboratories、Quest Diagnostics、BD、bioMérieux、Cardinal Health、Cepheid、Trinity Biotech、Quidel Corporation、Bio-Rad Laboratoriesなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

感染症POC診断市場は、種類と用途によって区分されます。世界の感染症POC診断市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他

【用途別セグメント】
病院ベッドサイド、緊急医療・小売クリニック、家庭・自己診断、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 感染症POC診断製品概要
- 種類別市場（イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他）
- 用途別市場（病院ベッドサイド、緊急医療・小売クリニック、家庭・自己診断、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の感染症POC診断販売量予測2017-2028
- 世界の感染症POC診断売上予測2017-2028
- 感染症POC診断の地域別販売量
- 感染症POC診断の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別感染症POC診断販売量
- 主要メーカー別感染症POC診断売上
- 主要メーカー別感染症POC診断価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他）
- 感染症POC診断の種類別販売量
- 感染症POC診断の種類別売上
- 感染症POC診断の種類別価格
・用途別市場規模（病院ベッドサイド、緊急医療・小売クリニック、家庭・自己診断、その他）
- 感染症POC診断の用途別販売量
- 感染症POC診断の用途別売上
- 感染症POC診断の用途別価格
・北米市場
- 北米の感染症POC診断市場規模（種類別、用途別）
- 主要国別の感染症POC診断市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの感染症POC診断市場規模（種類別、用途別）
- 主要国別の感染症POC診断市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の感染症POC診断市場規模（種類別、用途別）
- 主要国別の感染症POC診断市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の感染症POC診断市場規模（種類別、用途別）
- 主要国別の感染症POC診断市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの感染症POC診断市場規模（種類別、用途別）
- 主要国別の感染症POC診断市場規模（トルコ、サウジアラビア）
・企業情報
F. Hoffmann-La Roche、Thermo Fisher Scientific、Abbott Laboratories、Quest Diagnostics、BD、bioMérieux、Cardinal Health、Cepheid、Trinity Biotech、Quidel Corporation、Bio-Rad Laboratories
・産業チェーン及び販売チャネル分析
- 感染症POC診断の産業チェーン分析
- 感染症POC診断の原材料
- 感染症POC診断の生産プロセス
- 感染症POC診断の販売及びマーケティング
- 感染症POC診断の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 感染症POC診断の産業動向
- 感染症POC診断のマーケットドライバー
- 感染症POC診断の課題
- 感染症POC診断の阻害要因
・主な調査結果

Diagnostic tests are important for diagnosing diseases and for improving global health. Traditional diagnoses ofinfectious disease resulted in inaccurate results and were time-consuming.This flaw led to the emergence of rapid.accurate, and portable point-of-care testing products in the market. POC testing enables faster diagnosis of infectious disease near the patient site providing quick results、 Severalresearchers are now focused on the development of multiplex point-of-care diagnostic technologies. These MPOCTdevices consist of hybridization papers, array settings, bead technology, or microftuidic systems that reduce the assaysteps and provide diagnosis results in 15-30 minutes.
Market Analysis and Insights: Global Infectious Disease POC Diagnostic Market
Due to the COVID-19 pandemic, the global Infectious Disease POC Diagnostic market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Lateral Flow Immunoassay accounting for % of the Infectious Disease POC Diagnostic global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital Bedside segment is altered to an % CAGR throughout this forecast period.
China Infectious Disease POC Diagnostic market size is valued at US$ million in 2021, while the US and Europe Infectious Disease POC Diagnostic are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Infectious Disease POC Diagnostic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Infectious Disease POC Diagnostic include F. Hoffmann-La Roche, Thermo Fisher Scientific, Abbott Laboratories, Quest Diagnostics, BD, bioMérieux, Cardinal Health, Cepheid and Trinity Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Infectious Disease POC Diagnostic Scope and Segment
Infectious Disease POC Diagnostic market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Infectious Disease POC Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Lateral Flow Immunoassay
Agglutination Test
Flow-Through Test
Molecular Diagnostics
Others
Segment by Application
Hospital Bedside
Urgent Care and Retail Clinics
Home and Self-Testing
Others
By Company
F. Hoffmann-La Roche
Thermo Fisher Scientific
Abbott Laboratories
Quest Diagnostics
BD
bioMérieux
Cardinal Health
Cepheid
Trinity Biotech
Quidel Corporation
Bio-Rad Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Infectious Disease POC Diagnostic Product Introduction
1.2 Market by Type
1.2.1 Global Infectious Disease POC Diagnostic Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Lateral Flow Immunoassay
1.2.3 Agglutination Test
1.2.4 Flow-Through Test
1.2.5 Molecular Diagnostics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Infectious Disease POC Diagnostic Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Bedside
1.3.3 Urgent Care and Retail Clinics
1.3.4 Home and Self-Testing
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Infectious Disease POC Diagnostic Sales Estimates and Forecasts 2017-2028
2.2 Global Infectious Disease POC Diagnostic Revenue Estimates and Forecasts 2017-2028
2.3 Global Infectious Disease POC Diagnostic Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Infectious Disease POC Diagnostic Sales by Region
2.4.1 Global Infectious Disease POC Diagnostic Sales by Region (2017-2022)
2.4.2 Global Sales Infectious Disease POC Diagnostic by Region (2023-2028)
2.5 Global Infectious Disease POC Diagnostic Revenue by Region
2.5.1 Global Infectious Disease POC Diagnostic Revenue by Region (2017-2022)
2.5.2 Global Infectious Disease POC Diagnostic Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Infectious Disease POC Diagnostic Sales by Manufacturers
3.1.1 Global Top Infectious Disease POC Diagnostic Manufacturers by Sales (2017-2022)
3.1.2 Global Infectious Disease POC Diagnostic Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Infectious Disease POC Diagnostic in 2021
3.2 Global Infectious Disease POC Diagnostic Revenue by Manufacturers
3.2.1 Global Infectious Disease POC Diagnostic Revenue by Manufacturers (2017-2022)
3.2.2 Global Infectious Disease POC Diagnostic Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Infectious Disease POC Diagnostic Revenue in 2021
3.3 Global Infectious Disease POC Diagnostic Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Infectious Disease POC Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Infectious Disease POC Diagnostic Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Infectious Disease POC Diagnostic Sales by Type
4.1.1 Global Infectious Disease POC Diagnostic Historical Sales by Type (2017-2022)
4.1.2 Global Infectious Disease POC Diagnostic Forecasted Sales by Type (2023-2028)
4.1.3 Global Infectious Disease POC Diagnostic Sales Market Share by Type (2017-2028)
4.2 Global Infectious Disease POC Diagnostic Revenue by Type
4.2.1 Global Infectious Disease POC Diagnostic Historical Revenue by Type (2017-2022)
4.2.2 Global Infectious Disease POC Diagnostic Forecasted Revenue by Type (2023-2028)
4.2.3 Global Infectious Disease POC Diagnostic Revenue Market Share by Type (2017-2028)
4.3 Global Infectious Disease POC Diagnostic Price by Type
4.3.1 Global Infectious Disease POC Diagnostic Price by Type (2017-2022)
4.3.2 Global Infectious Disease POC Diagnostic Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Infectious Disease POC Diagnostic Sales by Application
5.1.1 Global Infectious Disease POC Diagnostic Historical Sales by Application (2017-2022)
5.1.2 Global Infectious Disease POC Diagnostic Forecasted Sales by Application (2023-2028)
5.1.3 Global Infectious Disease POC Diagnostic Sales Market Share by Application (2017-2028)
5.2 Global Infectious Disease POC Diagnostic Revenue by Application
5.2.1 Global Infectious Disease POC Diagnostic Historical Revenue by Application (2017-2022)
5.2.2 Global Infectious Disease POC Diagnostic Forecasted Revenue by Application (2023-2028)
5.2.3 Global Infectious Disease POC Diagnostic Revenue Market Share by Application (2017-2028)
5.3 Global Infectious Disease POC Diagnostic Price by Application
5.3.1 Global Infectious Disease POC Diagnostic Price by Application (2017-2022)
5.3.2 Global Infectious Disease POC Diagnostic Price Forecast by Application (2023-2028)
6 North America
6.1 North America Infectious Disease POC Diagnostic Market Size by Type
6.1.1 North America Infectious Disease POC Diagnostic Sales by Type (2017-2028)
6.1.2 North America Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
6.2 North America Infectious Disease POC Diagnostic Market Size by Application
6.2.1 North America Infectious Disease POC Diagnostic Sales by Application (2017-2028)
6.2.2 North America Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
6.3 North America Infectious Disease POC Diagnostic Market Size by Country
6.3.1 North America Infectious Disease POC Diagnostic Sales by Country (2017-2028)
6.3.2 North America Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Infectious Disease POC Diagnostic Market Size by Type
7.1.1 Europe Infectious Disease POC Diagnostic Sales by Type (2017-2028)
7.1.2 Europe Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
7.2 Europe Infectious Disease POC Diagnostic Market Size by Application
7.2.1 Europe Infectious Disease POC Diagnostic Sales by Application (2017-2028)
7.2.2 Europe Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
7.3 Europe Infectious Disease POC Diagnostic Market Size by Country
7.3.1 Europe Infectious Disease POC Diagnostic Sales by Country (2017-2028)
7.3.2 Europe Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Infectious Disease POC Diagnostic Market Size by Type
8.1.1 Asia Pacific Infectious Disease POC Diagnostic Sales by Type (2017-2028)
8.1.2 Asia Pacific Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
8.2 Asia Pacific Infectious Disease POC Diagnostic Market Size by Application
8.2.1 Asia Pacific Infectious Disease POC Diagnostic Sales by Application (2017-2028)
8.2.2 Asia Pacific Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
8.3 Asia Pacific Infectious Disease POC Diagnostic Market Size by Region
8.3.1 Asia Pacific Infectious Disease POC Diagnostic Sales by Region (2017-2028)
8.3.2 Asia Pacific Infectious Disease POC Diagnostic Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Infectious Disease POC Diagnostic Market Size by Type
9.1.1 Latin America Infectious Disease POC Diagnostic Sales by Type (2017-2028)
9.1.2 Latin America Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
9.2 Latin America Infectious Disease POC Diagnostic Market Size by Application
9.2.1 Latin America Infectious Disease POC Diagnostic Sales by Application (2017-2028)
9.2.2 Latin America Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
9.3 Latin America Infectious Disease POC Diagnostic Market Size by Country
9.3.1 Latin America Infectious Disease POC Diagnostic Sales by Country (2017-2028)
9.3.2 Latin America Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Infectious Disease POC Diagnostic Market Size by Type
10.1.1 Middle East and Africa Infectious Disease POC Diagnostic Sales by Type (2017-2028)
10.1.2 Middle East and Africa Infectious Disease POC Diagnostic Revenue by Type (2017-2028)
10.2 Middle East and Africa Infectious Disease POC Diagnostic Market Size by Application
10.2.1 Middle East and Africa Infectious Disease POC Diagnostic Sales by Application (2017-2028)
10.2.2 Middle East and Africa Infectious Disease POC Diagnostic Revenue by Application (2017-2028)
10.3 Middle East and Africa Infectious Disease POC Diagnostic Market Size by Country
10.3.1 Middle East and Africa Infectious Disease POC Diagnostic Sales by Country (2017-2028)
10.3.2 Middle East and Africa Infectious Disease POC Diagnostic Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Corporation Information
11.1.2 F. Hoffmann-La Roche Overview
11.1.3 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 F. Hoffmann-La Roche Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Thermo Fisher Scientific Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Corporation Information
11.3.2 Abbott Laboratories Overview
11.3.3 Abbott Laboratories Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott Laboratories Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Laboratories Recent Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Corporation Information
11.4.2 Quest Diagnostics Overview
11.4.3 Quest Diagnostics Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Quest Diagnostics Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Quest Diagnostics Recent Developments
11.5 BD
11.5.1 BD Corporation Information
11.5.2 BD Overview
11.5.3 BD Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 BD Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 BD Recent Developments
11.6 bioMérieux
11.6.1 bioMérieux Corporation Information
11.6.2 bioMérieux Overview
11.6.3 bioMérieux Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 bioMérieux Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 bioMérieux Recent Developments
11.7 Cardinal Health
11.7.1 Cardinal Health Corporation Information
11.7.2 Cardinal Health Overview
11.7.3 Cardinal Health Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Cardinal Health Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Cardinal Health Recent Developments
11.8 Cepheid
11.8.1 Cepheid Corporation Information
11.8.2 Cepheid Overview
11.8.3 Cepheid Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Cepheid Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cepheid Recent Developments
11.9 Trinity Biotech
11.9.1 Trinity Biotech Corporation Information
11.9.2 Trinity Biotech Overview
11.9.3 Trinity Biotech Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Trinity Biotech Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Trinity Biotech Recent Developments
11.10 Quidel Corporation
11.10.1 Quidel Corporation Corporation Information
11.10.2 Quidel Corporation Overview
11.10.3 Quidel Corporation Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Quidel Corporation Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Quidel Corporation Recent Developments
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Corporation Information
11.11.2 Bio-Rad Laboratories Overview
11.11.3 Bio-Rad Laboratories Infectious Disease POC Diagnostic Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Bio-Rad Laboratories Infectious Disease POC Diagnostic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bio-Rad Laboratories Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Infectious Disease POC Diagnostic Industry Chain Analysis
12.2 Infectious Disease POC Diagnostic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Infectious Disease POC Diagnostic Production Mode & Process
12.4 Infectious Disease POC Diagnostic Sales and Marketing
12.4.1 Infectious Disease POC Diagnostic Sales Channels
12.4.2 Infectious Disease POC Diagnostic Distributors
12.5 Infectious Disease POC Diagnostic Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Infectious Disease POC Diagnostic Industry Trends
13.2 Infectious Disease POC Diagnostic Market Drivers
13.3 Infectious Disease POC Diagnostic Market Challenges
13.4 Infectious Disease POC Diagnostic Market Restraints
14 Key Findings in The Global Infectious Disease POC Diagnostic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の感染症POC診断市場インサイト及び予測（イムノクロマトグラフィー、凝集反応、フロースルー検査、分子診断、その他）(Global Infectious Disease POC Diagnostic Market Insights, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • ヨーネ病診断の世界市場見通し2023年-2029年
  • 世界の分子診断感染症検査市場インサイト及び予測（細菌感染症検査、ウイルス感染症検査、寄生虫感染症検査）
  • 世界のペット感染症スクリーニング市場インサイト及び予測（フィラリア症、ライム病、エールリヒア症、その他）
  • 世界の感染症POC診断市場2022年：イムノクロマトグラフィー、凝集反応、フロースルーテスト、分子診断、その他
  • 世界の迅速診断検査キット市場2022年：イムノクロマトグラフィー、凝集反応アッセイ、免疫クロマトグラフィーアッセイ、免疫スポットアッセイ